Valuation: Sartorius Stedim Biotech SA

Market Cap 18.07B 20.68B 16.67B 15.37B 28.97B 1,991B 29.61B 199B 78.38B 975B 77.65B 75.94B 3,357B P/E 2026 *
47.2x
P/E 2027 * 37.1x
Enterprise Value 20.08B 22.98B 18.53B 17.08B 32.19B 2,213B 32.91B 221B 87.11B 1,084B 86.29B 84.4B 3,731B EV / Sales 2026 *
6.34x
EV / Sales 2027 * 5.68x
Free-Float
28.47%
Yield 2026 *
0.46%
Yield 2027 * 0.55%
Manager TitleAgeSince
Chief Executive Officer 51 28/03/2023
Chief Tech/Sci/R&D Officer 61 08/09/2011
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 07/04/2015
Director/Board Member 69 07/04/2015
Director/Board Member 69 14/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%+7.19%-18.59%-5.86% 175B
-0.43%-0.80%-7.15%-3.93% 106B
-0.03%+1.47%+5.13%+60.04% 59.91B
+0.66%+0.96%+37.64%+54.65% 51.95B
-1.10%+4.10%-11.56%-38.29% 43.58B
-3.21%-3.05% - - 33.65B
-1.71%+2.25%-8.63%-44.43% 29.58B
-1.16%+1.28%+69.87%-6.85% 25.31B
-1.49%+0.85%-3.43%-4.01% 21.23B
Average -0.73%+1.58%+7.91%+1.41% 60.79B
Weighted average by Cap. +0.09%+2.75%-1.60%+3.40%

Financials

2026 *2027 *
Net sales 3.17B 3.62B 2.92B 2.69B 5.07B 349B 5.19B 34.91B 13.73B 171B 13.6B 13.3B 588B 3.5B 4B 3.23B 2.97B 5.6B 385B 5.73B 38.55B 15.16B 189B 15.02B 14.69B 649B
Net income 380M 435M 351M 323M 609M 41.89B 623M 4.19B 1.65B 20.51B 1.63B 1.6B 70.62B 475M 543M 438M 404M 761M 52.33B 778M 5.24B 2.06B 25.63B 2.04B 2B 88.23B
Net Debt 2.01B 2.3B 1.86B 1.71B 3.23B 222B 3.3B 22.2B 8.73B 109B 8.65B 8.46B 374B 1.77B 2.02B 1.63B 1.5B 2.83B 195B 2.9B 19.5B 7.67B 95.42B 7.6B 7.43B 328B
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-